Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Maral Mouradian

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Neurology|January 24, 2002
Recent advances in the genetics and pathogenesis of Parkinson diseaseM Maral Mouradian
Neurobiology of Disease|January 17, 2012
MicroRNAs in Parkinson's diseaseM Maral Mouradian
Pharmacology & Therapeutics|January 4, 2012
Transglutaminase 2: biology, relevance to neurodegenerative diseases and therapeutic implicationsHilary Grosso, M Maral Mouradian
Cell Cycle (Georgetown, Tex.)|April 21, 2010
MicroRNAs in neurodegenerative disordersEunsung Junn, M Maral Mouradian
International Journal of Molecular Sciences|February 24, 2024
Pathogenetic Contributions and Therapeutic Implications of Transglutaminase 2 in Neurodegenerative DiseasesJun Liu, M Maral Mouradian
Neuroscience Letters|February 20, 2002
Human alpha-synuclein over-expression increases intracellular reactive oxygen species levels and susceptibility to dopamineEunsung Junn, M Maral Mouradian
Pharmacology & Therapeutics|October 20, 2011
MicroRNAs in neurodegenerative diseases and their therapeutic potentialEunsung Junn, M Maral Mouradian
Methods in Molecular Medicine|February 15, 2011
Transcription mechanisms for dopamine receptor genesS H Lee, M Maral Mouradian
Expert Opinion on Biological Therapy|May 25, 2004
Delivery of transgenically modified adult bone marrow cells to the rodent central nervous systemSuhayl Dhib-Jalbut, M Maral Mouradian
Methods in Molecular Medicine|February 15, 2011
Detection of DNA/Protein Interactions in Dopamine Receptor GenesS H Lee, M Maral Mouradian
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Neurology|January 24, 2002
Recent advances in the genetics and pathogenesis of Parkinson diseaseM Maral Mouradian
Neurobiology of Disease|January 17, 2012
MicroRNAs in Parkinson's diseaseM Maral Mouradian
Pharmacology & Therapeutics|January 4, 2012
Transglutaminase 2: biology, relevance to neurodegenerative diseases and therapeutic implicationsHilary Grosso, M Maral Mouradian
Cell Cycle (Georgetown, Tex.)|April 21, 2010
MicroRNAs in neurodegenerative disordersEunsung Junn, M Maral Mouradian
International Journal of Molecular Sciences|February 24, 2024
Pathogenetic Contributions and Therapeutic Implications of Transglutaminase 2 in Neurodegenerative DiseasesJun Liu, M Maral Mouradian
Neuroscience Letters|February 20, 2002
Human alpha-synuclein over-expression increases intracellular reactive oxygen species levels and susceptibility to dopamineEunsung Junn, M Maral Mouradian
Pharmacology & Therapeutics|October 20, 2011
MicroRNAs in neurodegenerative diseases and their therapeutic potentialEunsung Junn, M Maral Mouradian
Methods in Molecular Medicine|February 15, 2011
Transcription mechanisms for dopamine receptor genesS H Lee, M Maral Mouradian
Expert Opinion on Biological Therapy|May 25, 2004
Delivery of transgenically modified adult bone marrow cells to the rodent central nervous systemSuhayl Dhib-Jalbut, M Maral Mouradian
Methods in Molecular Medicine|February 15, 2011
Detection of DNA/Protein Interactions in Dopamine Receptor GenesS H Lee, M Maral Mouradian
Pageof 8